Shareholding17 Aug 2026, 08:24 am
Sudarshan Pharma: Promoter Shareholding Disclosure Filed
AI Summary
Sudarshan Pharma Industries Ltd has filed a disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011. The filing pertains to changes in the shareholding of the promoter group, Vasantrai Ratilal. Specific details of the shareholding changes, including acquisition or disposal of shares, are provided in the enclosed disclosure. The company has requested the BSE to take this information on record.
Key Highlights
- Disclosure filed under SEBI Takeover Regulations.
- Pertains to promoter group shareholding changes.
- Filed by Sudarshan Pharma Industries Ltd.
- Dated August 14, 2026.
- BSE Scrip Code: 543828.
Price Impact
More from SUDARSHAN